These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 22275118)

  • 1. The differential regulation of p38α by the neuronal kinase interaction motif protein tyrosine phosphatases, a detailed molecular study.
    Francis DM; Kumar GS; Koveal D; Tortajada A; Page R; Peti W
    Structure; 2013 Sep; 21(9):1612-23. PubMed ID: 23932588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma.
    Yang L; Sun X; Ye Y; Lu Y; Zuo J; Liu W; Elcock A; Zhu S
    Front Oncol; 2019; 9():1294. PubMed ID: 31828036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the regulation of the mitogen-activated protein (MAP) kinase p38α by the dual specificity phosphatase 16 MAP kinase binding domain in solution.
    Kumar GS; Zettl H; Page R; Peti W
    J Biol Chem; 2013 Sep; 288(39):28347-56. PubMed ID: 23926106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.
    Akella R; Min X; Wu Q; Gardner KH; Goldsmith EJ
    Structure; 2010 Dec; 18(12):1571-8. PubMed ID: 21134636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the hinge glycine flip and the activation loop: novel approach to potent p38α inhibitors.
    Martz KE; Dorn A; Baur B; Schattel V; Goettert MI; Mayer-Wrangowski SC; Rauh D; Laufer SA
    J Med Chem; 2012 Sep; 55(17):7862-74. PubMed ID: 22897496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-amino-pyrazoles as potent and selective p38α inhibitors.
    Das J; Moquin RV; Dyckman AJ; Li T; Pitt S; Zhang R; Shen DR; McIntyre KW; Gillooly K; Doweyko AM; Newitt JA; Sack JS; Zhang H; Kiefer SE; Kish K; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6886-9. PubMed ID: 21035336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective lead.
    Soth M; Abbot S; Abubakari A; Arora N; Arzeno H; Billedeau R; Dewdney N; Durkin K; Frauchiger S; Ghate M; Goldstein DM; Hill RJ; Kuglstatter A; Li F; Loe B; McCaleb K; McIntosh J; Papp E; Park J; Stahl M; Sung ML; Suttman R; Swinney DC; Weller P; Wong B; Zecic H; Gabriel T
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3452-6. PubMed ID: 21515047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferential NMR/X-ray-based structure determination of a dibenzo[a,d]cycloheptenone inhibitor-p38α MAP kinase complex in solution.
    Honndorf VS; Coudevylle N; Laufer S; Becker S; Griesinger C; Habeck M
    Angew Chem Int Ed Engl; 2012 Mar; 51(10):2359-62. PubMed ID: 22275118
    [No Abstract]   [Full Text] [Related]  

  • 9. The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography.
    Gill A; Cleasby A; Jhoti H
    Chembiochem; 2005 Mar; 6(3):506-12. PubMed ID: 15696598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein.
    Lee MR; Dominguez C
    Curr Med Chem; 2005; 12(25):2979-94. PubMed ID: 16378500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR structure determination in solution: a critique and comparison with X-ray crystallography.
    Wagner G; Hyberts SG; Havel TF
    Annu Rev Biophys Biomol Struct; 1992; 21():167-98. PubMed ID: 1525468
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.